Literature DB >> 25305131

The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line.

Tsai-Der Chuang1, Matthew Ho2, Omid Khorram3.   

Abstract

Uterine leiomyosarcoma is a relatively rare malignancy with high mortality due to metastasis and chemoresistance. Leiomyosarcomas share similar morphological characteristics with leiomyomas which are considered to have the potential of transformation into leiomyosarcoma. Accumulated evidence suggests that microRNAs acting as regulators of gene expression at the posttranscriptional level play key roles in diverse biological processes including cellular transformation and tumorigenesis. We hypothesized that miR-200c, whose expression is altered in leiomyomas, equally plays a key role in pathogenesis of leiomyosarcoma. Using SK-LMS-1 leiomyosarcoma cell line as an in vitro model here, we found that the level of expression of miR-200c was significantly lower as compared to isolated leiomyoma smooth muscle cells. Overexpression (gain-of-function) of miR-200c in SK-LMS-1 through direct interaction with 3'-untranslated region of IKBKB, IL8, CDK2, and CCNE2, respectively, resulted in suppression of their expression as determined by quantitative polymerase chain reaction and Western blot analysis. Additionally, gain-of-function of miR-200c through inhibition of IKBKB expression resulted in decreased p65 transcriptional activity in IL8 promoter. Gain-of-function of miR-200c also increased SK-LMS-1 caspase 3/7 activity and inhibited their proliferation and migration. In summary, the results suggest that a progressive decline in miR-200c expression which alters transcriptional regulation of specific target genes that control nuclear factor-κB signaling pathway, inflammation, cell cycle, and migration, in part may promote development and progression of leiomyosarcomas, including their transformation from leiomyomas.
© The Author(s) 2014.

Entities:  

Keywords:  CCNE2; CDK2; IKBKB; IL8; leiomyosarcomas; miR-200c

Mesh:

Substances:

Year:  2014        PMID: 25305131     DOI: 10.1177/1933719114553450

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  8 in total

1.  Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma.

Authors:  Tsai-Der Chuang; Omid Khorram
Journal:  Fertil Steril       Date:  2019-12       Impact factor: 7.329

Review 2.  Malignant tumors of the uterine corpus: molecular background of their origin.

Authors:  D Brany; D Dvorska; M Nachajova; P Slavik; T Burjanivova
Journal:  Tumour Biol       Date:  2015-08-26

3.  Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma.

Authors:  Tsai-Der Chuang; Yeming Xie; Wei Yan; Omid Khorram
Journal:  Fertil Steril       Date:  2018-05       Impact factor: 7.329

4.  Dysregulated microRNA expression in IL-4 transgenic mice, an animal model of atopic dermatitis.

Authors:  Lei Bao; Cecilia S Chau; Zhengdeng Lei; Hong Hu; Angelina G Chan; Kyle T Amber; Mark Maienschein-Cline; Maria M Tsoukas
Journal:  Arch Dermatol Res       Date:  2021-01-12       Impact factor: 3.017

5.  Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.

Authors:  Bruna Cristine de Almeida; Natalia Garcia; Giovana Maffazioli; Laura Gonzalez dos Anjos; Edmund Chada Baracat; Katia Candido Carvalho
Journal:  Int J Mol Sci       Date:  2017-12-25       Impact factor: 5.923

6.  Effect of 2-methoxyestradiol on SK-LMS-1 uterine leiomyosarcoma cells.

Authors:  Ji-Sun Lee; Changhwan Ahn; Hee Young Kang; Eui-Bae Jeung
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

Review 7.  The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids-From Bench to Bedside.

Authors:  Michał Ciebiera; Marta Włodarczyk; Stanisław Zgliczyński; Tomasz Łoziński; Klaudia Walczak; Artur Czekierdowski
Journal:  Int J Mol Sci       Date:  2020-04-24       Impact factor: 5.923

8.  Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?

Authors:  Laura Gonzalez Dos Anjos; Bruna Cristine de Almeida; Thais Gomes de Almeida; André Mourão Lavorato Rocha; Giovana De Nardo Maffazioli; Fernando Augusto Soares; Isabela Werneck da Cunha; Edmund Chada Baracat; Katia Candido Carvalho
Journal:  Cancers (Basel)       Date:  2018-09-06       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.